Posted on 12/19/18
Eyenovia Prices Public Offering of Common Stock
NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its . . .
Posted on 12/19/18
Roivant Sciences and Daiichi Sankyo Enter into Broad Pipeline Partnership
Roivant Sciences today announced that it has entered into a collaboration with Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) to facilitate the out-licensing of investigational medicines. . . .
Posted on 12/19/18
Pfizer and GlaxoSmithKline Announce Joint Venture
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company . . .
Posted on 12/19/18
Ochsner Health System and Geneva Health Solutions Partner
NEW YORK--(BUSINESS WIRE)--Today, Ochsner Health System – a nationally-recognized healthcare system based in Louisiana – announced a new partnership with Geneva Health Solutions (GHS) – the . . .
Posted on 12/19/18
Johnson & Johnson: Caution Here
SummaryJohnson & Johnson has seen harsh times as an old asbestos claim is playing up again.Shares have been hit hard as this times it looks serious, . . .
Posted on 12/19/18
How Safe Is Johnson & Johnson's Dividend?
SummaryJohnson & Johnson is both a Dividend Aristocrat and a Dividend King, and is one of the most well-known dividend growth stocks in the public markets.However, . . .
Posted on 12/19/18
3 Reasons Why Pfizer's Latest Dividend Hike Is Better Than You Might Think
Congratulations, Pfizer (NYSE:PFE) shareholders. You just got a nice raise.Last week, the big pharma company announced that its board of directors had approved an increase in . . .
Posted on 12/19/18
Celgene's Stock Is Fairly Valued Even In Worst-Case Revlimid Scenario
Summary Celgene increased 2018 revenue expectations for the second time this year as strong growth continues. Celgene's rock-bottom Forward P/E of 6.59x and PEG Ratio of . . .
Posted on 12/19/18
Outlook Therapeutics Provides Business Update
CRANBURY, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported financial results and business highlights for its fiscal year ended . . .
Posted on 12/18/18
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical . . .
Posted on 12/18/18
What Do Johnson & Johnson And BP Have In Common?
SummaryJNJ plunged 10% on Friday on the news that the company was aware of the presence of asbestos in its baby powder for decades.The liabilities may . . .
Posted on 12/18/18
Johnson & Johnson Proves Its Psoriasis Drug Can Be A Big Contender
SummaryJohnson & Johnson shows that its psoriasis drug Tremfya can definitely go toe to toe with Novartis' Cosentyx.Cosentyx was shown to have a rapid onset of . . .
Posted on 12/18/18
Better Buy: Eli Lilly and Company vs. Merck & Co.
Pharmaceutical heavyweights Merck & Co. Inc. (NYSE:MRK) and Eli Lilly and Company(NYSE:LLY) are getting a lot of attention after outperforming the market by a mile in . . .
Posted on 12/18/18
Biohaven Closes $144M Public Offering Of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting migraine and neurological diseases, including rare . . .
Posted on 12/17/18
BioHiTech Global Completes Acquisition to Become the Largest Owner of the Nation's First HEBioT Renewable Resource Recovery Facility
BioHiTech Global, Inc. (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced it has completed the acquisition of . . .
Posted on 12/17/18
Neurotrope Announces $22.5 Million Registered Direct Offering
Neurotrope, Inc. (Nasdaq:NTRP) today announced the pricing of a registered direct offering of 5,012,677 shares of common stock and warrants to purchase up to an aggregate . . .
Posted on 12/17/18
MetroPlus Ranked New York City’s Highest-Rated Health Plan
NEW YORK--(BUSINESS WIRE)--MetroPlus Health Plan announced today that it has been ranked New York City’s highest-rated health plan, according to the New York State Department of . . .
Posted on 12/17/18
Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration
NEW YORK, TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY), Eisai Co., Ltd. and its U.S.-based precision medicine research & development subsidiary H3 Biomedicine, Inc. . . .
Posted on 12/17/18
Precision Medicine Group Acquires Stern Investor Relations
Precision Medicine Group, Inc. (Precision) today announced it has acquired Stern Investor Relations, Inc. (Stern IR), a leading investor relations firm for entrepreneurial biotechnology
Posted on 12/17/18
Cancer Genetics Terminates Proposed Merger with NovellusDx
RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular . . .
Posted on 12/17/18
Johnson & Johnson: Reuters Ripped Off The Band-Aid
Summary Reuters released a sobering report claiming that Johnson & Johnson had concealed knowledge that its baby powder contained asbestos and intentionally avoided disclosure. Regardless of . . .
Posted on 12/14/18
Bausch Health Companies Acquires 2 Possible Blockbuster Drugs For $200 Million From Synergy Pharmaceuticals
SummaryFirst-year Trulance sales indicate Trulance has the potential to reach blockbuster status.New to market blocks are skewing trajectory trends in the market.Gross sales of Trulance are . . .
Posted on 12/14/18
IPRO Wins Patient Empowerment Grant
IPRO has been awarded a grant through the New York State Health Foundation's (NYSHealth's) Patients as Partners initiative to strengthen the voices of patients and families . . .
Posted on 12/13/18
Zoetis Announces Authorization of $2 Billion Share Repurchase Program
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced that its Board of Directors has authorized a $2 billion multi-year share repurchase program as part of its . . .
Posted on 12/13/18
The Medicines Company to Offer $150 Million of Convertible Notes
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) announced that it proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024, subject to market . . .

